Webinars and Sponsored Roundtables — Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Roche Diagnostics

cobas e 411

Company

Roche Diagnostics

Name of instrument

cobas e 411

Contact

Brianna Frederick  

Email

brianna.frederick@roche.com

City, State

Indianapolis, IN

Phone

800-428-5074  

Website

https://diagnostics.roche.com/us/en/home.html

Type of instrument

immunoassay

Operational type/Model type

random access, continuous random access/benchtop

List price/First year sold in U.S.

—/2008

Targeted hospital bed size/Targeted test volume

< 100/daily: < 200; monthly: < 40,000; annual: < 500,000

Company manufactures instrument

no (manufactured by Hitachi High-Technologies)

Other models in this family of analyzers

—

No. of units in clinical use in U.S./Outside U.S. (countries)

> 800/> 10,000 (> 50 countries)

Dimensions (H × W × D)/Instrument footprint

disk: 31.4 × 47.2 × 28.7 in./9.4 sq. ft.; rack: 31.4 × 67 × 37.4 in./17.4 sq. ft. 

Weight empty/Weight fully loaded

disk: 397 lbs./397 lbs.; rack: 551 lbs./551 lbs.

No. of different measured assays onboard simultaneously

18 (18 can be run and calibrated at one time)

No. of user-definable (open chemistry) channels

0

Test throughput per hour/Assay run time

86 (86 tests in throughput)/9–27 min. (avg. 18 min.)

No. of direct ion-selective electrode channels

—

Detection methods

—

Stat time until completion/specimen throughput for ion-selective electrode

—

Stat time until completion/specimen throughput for basic metabolic panel

—

Stat time until completion/specimen throughput for complete metabolic panel

—

Typical time delay from ordering stat test until aspiration of sample

—

Fully automated microplate immunoassay system

no

Methodologies supported

electrochemiluminescence

Separation methodologies

magnetic particle

Stat time until completion of a ß-hCG test

~10 min. 

Stat time until completion of a cTn test

~10 min.

• Typical time delay from test order to aspiration of sample

< 1 min.

Approximate No. of tests per reagent set/Reagent type

100–200/self-contained multiuse

Reagents refrigerated onboard/Reagents ready to use

no (20° ±3°C)/yes

Reagent lot tracking/Reagent inventory

yes/yes

Reagent form/Reagents barcoded

liquid chemistry (closed reagent system)/yes

Separate reagent pack for each specimen/for each test run

no/no

Walkaway capability/Walkaway duration

yes/30–60 min. or 30 specimens (disk), 75 specimens (rack) or 2,000–3,000 tests/assays

Design of sample-handling system

disk: ring; rack: rack

Uses washable cuvettes/Uses disposable cuvettes

no/yes (can store up to 360 assay tips, 180 assay cups)

Min.–max. sample volume that can be aspirated at one time 

10–50 µL

Min. reaction volume/Min. specimen volume/Min. dead volume

100 µL/10 µL/100 µL

Dedicated pediatric sample cup

yes (dead volume: 50 µL)

Primary tube sampling

yes

Accommodates most standard tube sizes/Accepts nonstandard tube sizes

yes/yes (12 × 100 mm)

Pierces caps on primary tubes

no

Protects against probe collision

yes

Detects clots/liquid level/short sample

yes/yes/yes

Detection or quantitation for hemolysis, icterus, lipemia, clots

detection for clots; hemolysis, icterus, lipemia not available

Dilutes patient samples onboard/Susceptibility to carryover

yes (can be programmed to perform sample dilutions prior to analysis)/0 (uses disposable tips)

Automatic rerun capability

yes

Sample volume can be diluted to rerun out-of-linear-range high results

yes

Sample volume can be concentrated to rerun out-of-linear-range low results

yes

Autocalibration/Multipoint calibration supported

yes (calibrants are not stored onboard)/yes (recommended avg. frequency: 28 days)

Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays

—/—/—/—/28 days

Automatic programmable start/Automatic programmable shutdown

yes (4 min. avg. start-up time)/yes

Onboard real-time QC/Onboard software capability to review QC

yes/yes

Supports multiple QC lot numbers per analyte

yes

Waste management

automated collection onboard instrument

Sample barcode-reading capability/Autodiscrimination

yes (Interleaved 2 of 5, Codabar, Code 39, Code 128, PDF417)/yes

Lab can control analyzer from remote computer

no

Instrument can diagnose its own malfunctions

yes (operator intervention required to order parts)

System malfunctions can be diagnosed via remote monitoring

yes

UPS backup power supply

yes

Data-management capability/LIS or EHR systems interfaced

onboard/SCC Soft Computer, Meditech, Oracle Health, Epic, Clinisys, more

LIS interface provided/Bidirectional interface capability

yes (included in instrument price)/yes (broadcast download and host query)

Modem servicing provided/Service engineer on-site response time

yes/< 24 hrs.

Mean time between failures

368 days (displays error codes for troubleshooting)

Average scheduled maintenance time by lab personnel

daily: 5 min.; weekly: 6 min.; monthly: 11 min.

Maintenance records kept onboard for user/vendor

some records/some records

Maintenance training demonstration module onboard

yes

Training included with purchase/Avg. time for basic user training

yes (1 training slot)/1 week (at both vendor and customer sites)

Advanced operator training/Extra charge for follow-up or advanced training

yes (at vendor site)/yes

Warranty provided/Cost of annual service contract (24 h/7 d)

yes (1 year)/configuration dependent

Distinguishing features (supplied by company)

drives lab efficiency with standardized instrumentation, reference ranges, consumables, and usage; minimizes downtime with industry-leading engineering and service; 325-day mean time between repair visits (average); speeds up turnaround time for high-volume stat assays

More products
in this guide

DxC 500 AU Clinical Chemistry Analyzer
DxC 500i Clinical Analyzer
Pictus 500 (P500)
DS2 Elite Automated ELISA System
Stat Profile Prime Plus
VITROS XT 3400 Chemistry Systems
cobas pure integrated solutions 
B⋅R⋅A⋅H⋅M⋅S KRYPTOR compact PLUS